Clinical Study
A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics
Table 2
Characteristics of chemotherapy in the Chemo+ group (
).
| | | Parameters | (%)
Mean ± SD |
| | Type of CT | LV5-FU2 (%) | 4 (12) | | Folfox (%) | 19 (58) | | Xelox (%) | 3 (9) | | Folfiri (%) | 7 (21) |
| | Number of courses | Fluorouracil | 10.4 ± 5.7 | | Fluorouracil plus irinotecan | 8 ± 6.7 | | Fluorouracil plus oxaliplatin | 8.2 ± 3.8 |
| | Cumulative dose | Fluorouracil (mg) | 51580 ± 29520 | | Irinotecan (mg) | 2767 ± 2250 | | Oxaliplatin (mg) | 1250 ± 626 |
|
|
